首页> 外文期刊>Lab on a chip >Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform
【24h】

Sensitive detection of protein and miRNA cancer biomarkers using silicon-based photonic crystals and a resonance coupling laser scanning platform

机译:使用基于硅的光子晶体和共振耦合激光扫描平台对蛋白质和miRNA癌症生物标志物进行灵敏检测

获取原文
获取原文并翻译 | 示例
           

摘要

Enhancement of the fluorescent output of surface-based fluorescence assays by performing them upon nanostructured photonic crystal (PC) surfaces has been demonstrated to increase signal intensities by >8000 x. Using the multiplicative effects of optical resonant coupling to the PC in increasing the electric field intensity experienced by fluorescent labels ("enhanced excitation") and the spatially biased funneling of fluorophore emissions through coupling to PC resonances ("enhanced extraction"), PC enhanced fluorescence (PCEF) can be adapted to reduce the limits of detection of disease biomarker assays, and to reduce the size and cost of high sensitivity detection instrumentation. In this work, we demonstrate the first silicon-based PCEF detection platform for multiplexed biomarker assay. The sensor in this platform is a silicon-based PC structure, comprised of a SiO2 grating that is overcoated with a thin film of high refractive index TiO2 and is produced in a semiconductor foundry for low cost, uniform, and reproducible manufacturing. The compact detection instrument that completes this platform was designed to efficiently couple fluorescence excitation from a semiconductor laser to the resonant optical modes of the PC, resulting in elevated electric field strength that is highly concentrated within the region < 100 nm from the PC surface. This instrument utilizes a cylindrically focused line to scan a microarray in <1 min. To demonstrate the capabilities of this sensor-detector platform, microspot fluorescent sandwich immunoassays using secondary antibodies labeled with Cy5 for two cancer biomarkers (TNF-α and IL-3) were performed. Biomarkers were detected at concentrations as low as 0.1 pM. In a fluorescent microarray for detection of a breast cancer miRNA biomarker miR-21,the miRNA was detectable at a concentration of 0.6 pM.
机译:通过在纳米结构光子晶体(PC)表面上进行表面荧光检测,可以增强基于表面的荧光检测的荧光输出,从而使信号强度增加> 8000 x。利用光共振耦合到PC的乘法效应来增加荧光标记经历的电场强度(“增强激发”)和通过耦合到PC共振(“增强提取”)使荧光团发射发生空间偏向漏斗,PC增强了荧光(PCEF)可以降低疾病生物标志物检测的检测限,并减少高灵敏度检测仪器的尺寸和成本。在这项工作中,我们演示了第一个用于多重生物标志物测定的基于硅的PCEF检测平台。该平台中的传感器是基于硅的PC结构,由SiO2光栅组成,该SiO2光栅表面覆盖有高折射率TiO2薄膜,并在半导体铸造厂中生产,以实现低成本,均匀且可重复的制造。完善该平台的紧凑型检测仪器旨在将半导体激光器发出的荧光激发有效地耦合到PC的共振光学模式,从而产生增强的电场强度,该电场强度高度集中在距PC表面<100 nm的区域内。该仪器利用圆柱形聚焦线在不到1分钟的时间内扫描微阵列。为了证明该传感器-检测器平台的功能,使用了用Cy5标记的二级抗体对两种癌症生物标记物(TNF-α和IL-3)进行了微斑点荧光夹心免疫分析。检测到的生物标志物浓度低至0.1 pM。在用于检测乳腺癌miRNA生物标志物miR-21的荧光微阵列中,miRNA的浓度为0.6 pM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号